A new technology is poised to transform the discovery of microbial species and enzymes with specific in situ metabolic ...

Companion Cancer Diagnostics Market The rising incidence of cancer worldwide is a primary driver of the Global Companion Cancer Diagnostics ...

In a report released today, Matt Hewitt from Craig-Hallum assigned a Buy rating to NeoGenomics (NEO – Research Report). The company’s shares ...

A new technology developed by the Single-Cell Center at Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of ...

In a retrospective study of 315 patients with relapsed/refractory multiple myeloma, retreatment with previously refractory drugs achieved an overall response rate of 56.2% and median progression-free ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on NeoGenomics (NEO – Research Report). The company’s shares ...

Study uncovers the impact of myocardial infarction on the cardiac conduction system, revealing insights into arrhythmogenesis ...

Tests from Castle Biosciences, Pacific Edge Diagnostics, Interpace Biosciences, Clinical Genomics, and the University of Pittsburgh Medical Center will no longer be covered.

The work represents a major step forward in the technical capacity of the MERFISH. Multiplexed error-robust fluorescence in-situ hybridization (MERFISH) allows genome-scale imaging of RNAs in ...

Bone marrow biopsy is a term used to describe a surgical procedure in which a small portion of bone marrow is extracted from ...